|
FATE Fate Therapeutics Inc 1434316 |
| Balance Sheet |
|
Current Assets
|
291,909,000 |
|
Assets
|
440,694,000 |
|
Current Liabilities
|
38,522,000 |
|
Liabilities
|
121,968,000 |
|
Equity
|
318,726,000 |
|
Shares Out
|
113,878,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-122,874,000 |
|
Investing Cash Flow
|
12,218,000 |
| Market Analysis |
Market Cap
|
357,006,901 |
|
Price
|
0.94 |
|
BVPS
|
2.80 |
|
PB
|
0.33 |
|
EPS
|
-1.71 |
|
PS
|
6.55 |
|
FCF
|
-110,656,000 |
|
| Earnings |
|
| Jan |
Feb |
Mar |
|
|
2/26 |
-0.45 |
3/5 |
-1.64 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view FATE documents filed with the SEC.
FATE Filings
Clear
